- Home
- REAL vs TRVI Comparison
REAL vs TRVI Comparison
Compare REAL & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- TRVI
- Stock Information
- Founded
- REAL 2011
- TRVI 2011
- Country
- REAL United States
- TRVI United States
- Employees
- REAL N/A
- TRVI N/A
- Industry
- REAL Other Specialty Stores
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- TRVI Health Care
- Exchange
- REAL Nasdaq
- TRVI Nasdaq
- Market Cap
- REAL 871.2M
- TRVI 725.7M
- IPO Year
- REAL 2019
- TRVI 2019
- Fundamental
- Price
- REAL $9.28
- TRVI $9.57
- Analyst Decision
- REAL Strong Buy
- TRVI Strong Buy
- Analyst Count
- REAL 5
- TRVI 9
- Target Price
- REAL $11.10
- TRVI $20.72
- AVG Volume (30 Days)
- REAL 3.9M
- TRVI 2.8M
- Earning Date
- REAL 11-03-2025
- TRVI 11-05-2025
- Dividend Yield
- REAL N/A
- TRVI N/A
- EPS Growth
- REAL N/A
- TRVI N/A
- EPS
- REAL N/A
- TRVI N/A
- Revenue
- REAL $636,971,000.00
- TRVI N/A
- Revenue This Year
- REAL $14.27
- TRVI N/A
- Revenue Next Year
- REAL $9.94
- TRVI N/A
- P/E Ratio
- REAL N/A
- TRVI N/A
- Revenue Growth
- REAL 12.68
- TRVI N/A
- 52 Week Low
- REAL $2.33
- TRVI $2.36
- 52 Week High
- REAL $11.38
- TRVI $9.83
- Technical
- Relative Strength Index (RSI)
- REAL 70.78
- TRVI 76.12
- Support Level
- REAL $8.02
- TRVI $6.93
- Resistance Level
- REAL $9.50
- TRVI $8.78
- Average True Range (ATR)
- REAL 0.42
- TRVI 0.66
- MACD
- REAL 0.08
- TRVI 0.23
- Stochastic Oscillator
- REAL 90.39
- TRVI 94.31
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.